620 related articles for article (PubMed ID: 29204670)
1. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
[TBL] [Abstract][Full Text] [Related]
2. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis.
Li X; Liu C; Mao Z; Qi S; Song R; Zhou F
J Crit Care; 2021 Jun; 63():187-195. PubMed ID: 33012579
[TBL] [Abstract][Full Text] [Related]
4. Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.
Terayama T; Yamakawa K; Umemura Y; Aihara M; Fujimi S
Surg Infect (Larchmt); 2017 Apr; 18(3):225-233. PubMed ID: 28092497
[TBL] [Abstract][Full Text] [Related]
5. Identifying Septic Shock Populations Benefitting From Polymyxin B Hemoperfusion: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.
Nakata H; Yamakawa K; Kabata D; Umemura Y; Ogura H; Gando S; Shintani A; Shiraishi A; Saitoh D; Fujishima S; Mayumi T; Kushimoto S; Abe T; Shiino Y; Nakada TA; Tarui T; Hifumi T; Otomo Y; Okamoto K; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S;
Shock; 2020 Nov; 54(5):667-674. PubMed ID: 32195922
[TBL] [Abstract][Full Text] [Related]
6. Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.
Nakamura Y; Kitamura T; Kiyomi F; Hayakawa M; Hoshino K; Kawano Y; Yamasaki R; Nishida T; Mizunuma M; Ishikura H;
Crit Care; 2017 Jun; 21(1):134. PubMed ID: 28592318
[TBL] [Abstract][Full Text] [Related]
7. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients.
Srisawat N; Tungsanga S; Lumlertgul N; Komaenthammasophon C; Peerapornratana S; Thamrongsat N; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S; Tungsanga K; Kellum JA
Crit Care; 2018 Oct; 22(1):279. PubMed ID: 30367647
[TBL] [Abstract][Full Text] [Related]
8. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.
Payen DM; Guilhot J; Launey Y; Lukaszewicz AC; Kaaki M; Veber B; Pottecher J; Joannes-Boyau O; Martin-Lefevre L; Jabaudon M; Mimoz O; Coudroy R; Ferrandière M; Kipnis E; Vela C; Chevallier S; Mallat J; Robert R;
Intensive Care Med; 2015 Jun; 41(6):975-84. PubMed ID: 25862039
[TBL] [Abstract][Full Text] [Related]
9. Evidence and Perspectives on the Use of Polymyxin B-Immobilized Fiber Column Hemoperfusion among Critically Ill Patients.
Yamashita C; Moriyama K; Hasegawa D; Hara Y; Kuriyama N; Nakamura T; Shibata J; Komura H; Nishida O
Contrib Nephrol; 2018; 196():215-222. PubMed ID: 30041230
[TBL] [Abstract][Full Text] [Related]
10. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.
Dellinger RP; Bagshaw SM; Antonelli M; Foster DM; Klein DJ; Marshall JC; Palevsky PM; Weisberg LS; Schorr CA; Trzeciak S; Walker PM;
JAMA; 2018 Oct; 320(14):1455-1463. PubMed ID: 30304428
[TBL] [Abstract][Full Text] [Related]
11. Effects of polymyxin B hemoperfusion on hemodynamics and prognosis in septic shock patients.
Lee CT; Tu YK; Yeh YC; Chang T; Shih PY; Chao A; Huang HH; Cheng YJ; Yeh YC;
J Crit Care; 2018 Feb; 43():202-206. PubMed ID: 28915395
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
[TBL] [Abstract][Full Text] [Related]
13. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
[TBL] [Abstract][Full Text] [Related]
14. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
Nakamura T; Sugaya T; Koide H
Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
[TBL] [Abstract][Full Text] [Related]
15. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock.
Okubo A; Nakashima A; Doi S; Ueno T; Sasaki K; Esaki T; Masaki T
Clin Exp Nephrol; 2018 Oct; 22(5):1167-1173. PubMed ID: 29478200
[TBL] [Abstract][Full Text] [Related]
16. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.
Klein DJ; Foster D; Walker PM; Bagshaw SM; Mekonnen H; Antonelli M
Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853
[TBL] [Abstract][Full Text] [Related]
17. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.
Cruz DN; Perazella MA; Bellomo R; de Cal M; Polanco N; Corradi V; Lentini P; Nalesso F; Ueno T; Ranieri VM; Ronco C
Crit Care; 2007; 11(2):R47. PubMed ID: 17448226
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
Saito N; Sugiyama K; Ohnuma T; Kanemura T; Nasu M; Yoshidomi Y; Tsujimoto Y; Adachi H; Koami H; Tochiki A; Hori K; Wagatsuma Y; Matsumoto H
PLoS One; 2017; 12(3):e0173633. PubMed ID: 28358803
[TBL] [Abstract][Full Text] [Related]
20. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
Mitaka C; Tomita M
Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
